EXAGEN DIAGNOSTICS, INC. Patent applications |
Patent application number | Title | Published |
20150369824 | Methods for treating and diagnosing Systemic Lupus Erythematosus - Methods and reagents for diagnosing, prognosing, and treating systemic lupus erythematosus (SLE) are disclosed, involving calculating an SLE risk score for a subject based on a level of each of an erythrocyte C4d (EC4d) marker, a B-cell C4d (BC4d) marker, antinuclear antibodies (ANA), anti-Smith antibodies (anti-Sm) and optional rule-out markers (SS-B/La, Scl-70, Jo-1, CENP, MCV). | 12-24-2015 |
20130309698 | Methods for Diagnosing Systemic Lupus Erythematosus - The present invention provides methods of diagnosing and monitoring systemic lupus erythematosus. | 11-21-2013 |
20130216530 | Methods for optimizing biological response modifier therapy using therapeutic drug monitoring of immunosuppressants - The invention provides methods for treating humans in need of combined immunosuppressant and biological response modifier therapy. | 08-22-2013 |
20130079245 | Biomarkers for Ulcerative Colitis and Crohn's Disease - The present invention provides compositions and their use in diagnosing ulcerative colitis, Crohn's Disease, and inflammatory bowel disease. | 03-28-2013 |
20130065229 | BIOMARKERS FOR SYSTEMIC LUPUS ERYTHEMATOSUS - The present invention provides methods and reagents for diagnosing system lupus erythematosus and for monitoring system lupus erythematosus disease activity in a subject. | 03-14-2013 |
20130040835 | Genes predictive of anti-TNF response in inflammatory diseases - The present invention provides compositions and their use in predicting anti-tumor necrosis factor therapy response in a patient with an inflammatory disease. | 02-14-2013 |
20110301051 | Biomarkers for Ulcerative Colitis and Crohn's Disease - The present invention provides compositions and their use in diagnosing ulcerative colitis, Crohn's Disease, and inflammatory bowel disease. | 12-08-2011 |
20110262948 | Methods of Quantifying Methotrexate Metabolites - The present invention provides a method for efficiently converting methotrexate polyglutamates to methotrexate in a cellular extract by contacting the cellular extract with gamma glutamyl hydrolase under conditions suitable for efficient conversion of methotrexate polyglutamates to methotrexate. | 10-27-2011 |
20110177531 | Cell-Based Complement Activation Product Algorithm for Diagnosing Systemic Lupus Erythematosus - The present invention provides methods of diagnosing and monitoring systemic lupus erythematosus by measuring cell-based complement activation products (CB-CAPS) in a subject's blood. In particular, the invention describes a diagnostic method employing the measurement of multiple complement activation products on the surfaces of red blood cells, white blood cells, and platelets (e.g., EC4d, BC4d, PC4d, and ECR1). A diagnostic algorithm utilizing the determined levels of CB-CAPS is also disclosed. | 07-21-2011 |
20100184967 | Biomarkers for Inflammatory Bowel Disease and Irritable Bowel Syndrome - The present invention provides compositions and their use in diagnosing and/or distinguishing inflammatory bowel disease and irritable bowel syndrome. | 07-22-2010 |
20100184625 | Biomarkers for Inflammatory Bowel Disease and Irritable Bowel Syndrome - The present invention provides compositions and their use in diagnosing and/or distinguishing inflammatory bowel disease and irritable bowel syndrome. | 07-22-2010 |
20100159469 | Compositions and Methods for Breast Cancer Prognosis - The present invention provides novel compositions and their use in classifying breast tumors. | 06-24-2010 |
20100152062 | Biomarkers for Inflammatory Bowel Disease and Irritable Bowel Syndrome - The present invention provides compositions and their use in diagnosing and/or distinguishing inflammatory bowel disease and irritable bowel syndrome. | 06-17-2010 |
20090258370 | Acute Myelogenous Leukemia Biomarkers - The present invention provides novel compositions and their use in classifying acute myelogenous leukemia. | 10-15-2009 |
20090253139 | Compositions and methods for glioma classification - The present invention provides novel compositions and their use in classifying gliomas. In a preferred embodiment, the methods are used to discriminate between oligodendroglioma and glioblastoma. | 10-08-2009 |
20090233306 | Biomarkers for Inflammatory Bowel Disease and Irritable Bowel Syndrome - The present invention provides compositions and their use in diagnosing and/or distinguishing inflammatory bowel disease and irritable bowel syndrome. | 09-17-2009 |
20090233305 | Biomarkers for Inflammatory Bowel Disease and Irritable Bowel Syndrome - The present invention provides compositions and their use in diagnosing and/or distinguishing inflammatory bowel disease and irritable bowel syndrome. | 09-17-2009 |
20090233304 | Biomarkers for Inflammatory Bowel Disease and Irritable Bowel Syndrome - The present invention provides compositions and their use in diagnosing and/or distinguishing inflammatory bowel disease and irritable bowel syndrome. | 09-17-2009 |